CORT
NASDAQ · Pharmaceuticals
Corcept Therapeutics Inc
$110.29
-4.57 (-3.98%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-7.2% upside
Low Target
$62.31
Average Target
$102.33
High Target
$121.34
Current Price
$110.29
Current
$110.29
$110.29
Target
$102.33
$102.33
$62.31
$102.33 avg
$121.34
Scenario Analysis
Bear Case
$62.31
-43.5%
Low target
Base Case
$102.33
-7.2%
Avg target
Bull Case
$121.34
+10.0%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$126.38
-12.7% from high
52-Week Low
$28.66
+284.8% from low
50-Day SMA
$53.13
+107.6% vs SMA
200-Day SMA
$69.00
+59.8% vs SMA
RSI (14)
26.0
Oversold
Target vs 52W High
$102.33
-19.0% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +14.0% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +10.5% |
| MRK | Buy | 36 | 72% | $159.27 | +6.1% |
| PFE | Hold | 36 | 39% | $33.90 | +21.5% |
| BMY | Hold | 35 | 43% | $174.50 | +177.1% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -37.9% |
| ZTS | Hold | 24 | 50% | $209.87 | +193.9% |